To gain more insight into how FLCN acts to suppress renal tumorigenesis in BHD syndrome, we have investigated the role of FLCN in regulating cellular signaling pathways via protein and receptor phosphorylation by determining complete phosphoproteomic profiles. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.